ArticleMolecular cancer therapeutics2016

The Combination of Vemurafenib and Procaspase-3 Activation Is Synergistic in Mutant BRAF Melanomas.

Jessie Peh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.